Reference is made to the notification of the capital increase and listing of new shares on 28 April 2015.
As a consequence of the share capital increase following the share option exercise on 27 April 2015, the following shareholders in PCI Biotech Holding ASA have a shareholding that is subject to the disclosure requirements of the Norwegian Securities Trading Act:
Photocure ASA owns 1,483,339 shares, corresponding to 9.96% of the total amount of shares outstanding. Prior to the share capital increase registered on 28 April 2015, Photocure ASA owned 10.07% of the total amount of shares outstanding.
Vicama AS owns 743,288 shares, corresponding to 4.99% of the total amount of shares outstanding. Prior to the share capital increase registered on 28 April 2015, Vicama AS owned 5.05% of the total amount of shares outstanding.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.